Annals of Oncology

in this issue

in this issue
Ann Oncol 2009 20: 799; doi:10.1093/annonc/mdp248 [Extract] [Full Text] [PDF] [Request Permissions]  

editorials

R. Ferraldeschi and P. Lorigan

Extensive-stage small-cell lung cancer—moving beyond response rate?
Ann Oncol 2009 20: 801-802; doi:10.1093/annonc/mdp247 [Extract] [Full Text] [PDF] [Request Permissions]  

B. C. Pestalozzi

Brain metastases and subtypes of breast cancer
Ann Oncol 2009 20: 803-805; doi:10.1093/annonc/mdp246 [Extract] [Full Text] [PDF] [Request Permissions]  

reviews

Get checked abstract H. Izzedine, S. Ederhy, F. Goldwasser, J. C. Soria, G. Milano, A. Cohen, D. Khayat, and J. P. Spano

Management of hypertension in angiogenesis inhibitor-treated patients
Annals of Oncology Advance Access published on January 15, 2009
Ann Oncol 2009 20: 807-815; doi:10.1093/annonc/mdn713 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Get checked abstract P. J. Barrett-Lee, J. M. Dixon, C. Farrell, A. Jones, R. Leonard, N. Murray, C. Palmieri, C. J. Plummer, A. Stanley, and M. W. Verrill

Expert opinion on the use of anthracyclines in patients with advanced breast cancer at cardiac risk
Annals of Oncology Advance Access published on January 19, 2009
Ann Oncol 2009 20: 816-827; doi:10.1093/annonc/mdn728 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

original articles

lung cancer

Get checked abstract K. Hotta, K. Kiura, Y. Fujiwara, N. Takigawa, I. Oze, N. Ochi, M. Tabata, and M. Tanimoto

Association between incremental gains in the objective response rate and survival improvement in phase III trials of first-line chemotherapy for extensive disease small-cell lung cancer
Annals of Oncology Advance Access published on February 16, 2009
Ann Oncol 2009 20: 829-834; doi:10.1093/annonc/mdp020 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Get checked abstract K. Takeda, S. Negoro, T. Tamura, Y. Nishiwaki, S. Kudoh, S. Yokota, K. Matsui, H. Semba, K. Nakagawa, Y. Takada, M. Ando, T. Shibata, and N. Saijo

Phase III trial of docetaxel plus gemcitabine versus docetaxel in second-line treatment for non-small-cell lung cancer: results of a Japan Clinical Oncology Group trial (JCOG0104)
Annals of Oncology Advance Access published on January 22, 2009
Ann Oncol 2009 20: 835-841; doi:10.1093/annonc/mdn705 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract V. Ludovini, G. Bellezza, L. Pistola, F. Bianconi, L. Di Carlo, A. Sidoni, A. Semeraro, R. Del Sordo, F. R. Tofanetti, M. G. Mameli, G. Daddi, A. Cavaliere, M. Tonato, and L. Crinò

High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free survival in resected non-small-cell lung cancer patients
Annals of Oncology Advance Access published on January 19, 2009
Ann Oncol 2009 20: 842-849; doi:10.1093/annonc/mdn727 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract H. L. West, H. A. Wakelee, M. C. Perry, R. J. Belt, R. Chen, and C. Obasaju

Gemcitabine and pemetrexed administered in rapid sequence as front-line chemotherapy for advanced non-small-cell lung cancer: a phase II clinical trial
Annals of Oncology Advance Access published on January 15, 2009
Ann Oncol 2009 20: 850-856; doi:10.1093/annonc/mdn715 [Abstract] [Full Text] [PDF] [Request Permissions]  

breast cancer

Get checked abstract A. Merglen, H. M. Verkooijen, G. Fioretta, I. Neyroud-Caspar, V. Vinh-Hung, G. Vlastos, P. O. Chappuis, M. Castiglione, E. Rapiti, and C. Bouchardy

Hormonal therapy for oestrogen receptor-negative breast cancer is associated with higher disease-specific mortality
Annals of Oncology Advance Access published on January 15, 2009
Ann Oncol 2009 20: 857-861; doi:10.1093/annonc/mdn688 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract B. Corkery, J. Crown, M. Clynes, and N. O'Donovan

Epidermal growth factor receptor as a potential therapeutic target in triple-negative breast cancer
Annals of Oncology Advance Access published on January 15, 2009
Ann Oncol 2009 20: 862-867; doi:10.1093/annonc/mdn710 [Abstract] [Full Text] [PDF] [Supplementary Data] [Request Permissions]  

Get checked abstract T. Saeki, S. Noguchi, K. Aogi, H. Inaji, T. Tabei, and T. Ikeda

Evaluation of the safety and tolerability of oral TAS-108 in postmenopausal patients with metastatic breast cancer
Annals of Oncology Advance Access published on January 15, 2009
Ann Oncol 2009 20: 868-873; doi:10.1093/annonc/mdn714 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract M. Pensabene, I. Spagnoletti, I. Capuano, C. Condello, S. Pepe, A. Contegiacomo, G. Lombardi, G. Bevilacqua, and M. A. Caligo

Two mutations of BRCA2 gene at exon and splicing site in a woman who underwent oncogenetic counseling
Annals of Oncology Advance Access published on January 29, 2009
Ann Oncol 2009 20: 874-878; doi:10.1093/annonc/mdn724 [Abstract] [Full Text] [PDF] [Request Permissions]  

gastrointestinal tumors

Get checked abstract K. -L. Garm Spindler, N. Pallisgaard, A. A. Rasmussen, J. Lindebjerg, R. F. Andersen, D. Crüger, and A. Jakobsen

The importance of KRAS mutations and EGF61A>G polymorphism to the effect of cetuximab and irinotecan in metastatic colorectal cancer
Annals of Oncology Advance Access published on January 29, 2009
Ann Oncol 2009 20: 879-884; doi:10.1093/annonc/mdn712 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract I. Chau, A. R. Norman, D. Cunningham, J. Oates, R. Hawkins, T. Iveson, M. Nicolson, P. Harper, M. Seymour, and T. Hickish

The impact of primary tumour origins in patients with advanced oesophageal, oesophago–gastric junction and gastric adenocarcinoma—individual patient data from 1775 patients in four randomised controlled trials
Annals of Oncology Advance Access published on January 22, 2009
Ann Oncol 2009 20: 885-891; doi:10.1093/annonc/mdn716 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract D. Y. Zang, B. H. Lee, H.-C. Park, H. H. Song, H. J. Kim, J. Y. Jung, J. H. Kim, H. Y. Kim, J. H. Kwon, S. W. Hwang, S. R. Park, C. H. Park, K. O. Kim, M.-J. Kim, and K. M. Jang

Phase II study with oxaliplatin and S-1 for patients with metastatic colorectal cancer
Annals of Oncology Advance Access published on January 19, 2009
Ann Oncol 2009 20: 892-896; doi:10.1093/annonc/mdn721 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract Z. Sun, G.-L. Zhu, C. Lu, P.-T. Guo, B.-J. Huang, K. Li, Y. Xu, De-Ming Li, Z.-N. Wang, and H.-M. Xu

The impact of N-ratio in minimizing stage migration phenomenon in gastric cancer patients with insufficient number or level of lymph node retrieved: results from a Chinese mono-institutional study in 2159 patients
Annals of Oncology Advance Access published on January 29, 2009
Ann Oncol 2009 20: 897-905; doi:10.1093/annonc/mdn707 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract C. Carlomagno, A. Farella, L. Bucci, F. P. D'Armiento, G. Pesce, S. Pepe, L. Cannella, R. Pacelli, A. De Stefano, R. Solla, M. R. D'Armiento, and S. De Placido

Neo-adjuvant treatment of rectal cancer with capecitabine and oxaliplatin in combination with radiotherapy: a phase II study
Annals of Oncology Advance Access published on January 20, 2009
Ann Oncol 2009 20: 906-912; doi:10.1093/annonc/mdn719 [Abstract] [Full Text] [PDF] [Request Permissions]  

urogenital tumors

Get checked abstract M. Dror Michaelson, M. M. Regan, W. K. Oh, D. S. Kaufman, K. Olivier, S. Z. Michaelson, B. Spicer, C. Gurski, P. W. Kantoff, and M. R. Smith

Phase II study of sunitinib in men with advanced prostate cancer
Ann Oncol 2009 20: 913-920; doi:10.1093/annonc/mdp111 [Abstract] [Full Text] [PDF] [Request Permissions]  

head and neck cancer

Get checked abstract M. R. Posner, C. M. Norris, L. J. Wirth, D. M. Shin, K. J. Cullen, E. W. Winquist, C. R. Blajman, E. A. Mickiewicz, G. P. Frenette, L. F. Plinar, R. B. Cohen, L. M. Steinbrenner, J. M. Freue, V. A. Gorbunova, S. A. Tjulandin, L. E. Raez, D. R. Adkins, R. B. Tishler, M. R. Roessner, R. I. Haddad, and for the TAX 324 Study Group

Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservation
Annals of Oncology Advance Access published on January 29, 2009
Ann Oncol 2009 20: 921-927; doi:10.1093/annonc/mdn752 [Abstract] [Full Text] [PDF] [Supplementary Data] [Request Permissions]  

quality of life/supportive care/palliative care

Get checked abstract C. Pitceathly, P. Maguire, I. Fletcher, M. Parle, B. Tomenson, and F. Creed

Can a brief psychological intervention prevent anxiety or depressive disorders in cancer patients? A randomised controlled trial
Annals of Oncology Advance Access published on January 6, 2009
Ann Oncol 2009 20: 928-934; doi:10.1093/annonc/mdn708 [Abstract] [Full Text] [PDF] [Request Permissions]  

oncology practice

Get checked abstract R. Biffi, F. Orsi, S. Pozzi, U. Pace, G. Bonomo, L. Monfardini, P. Della Vigna, N. Rotmensz, D. Radice, M. G. Zampino, N. Fazio, F. de Braud, B. Andreoni, and A. Goldhirsch

Best choice of central venous insertion site for the prevention of catheter-related complications in adult patients who need cancer therapy: a randomized trial
Annals of Oncology Advance Access published on January 29, 2009
Ann Oncol 2009 20: 935-940; doi:10.1093/annonc/mdn701 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract G. Numico, M. Anfossi, G. Bertelli, E. Russi, G. Cento, N. Silvestris, C. Granetto, G. Di Costanzo, M. Occelli, E. Fea, O. Garrone, M. Gasco, I. Colantonio, and M. Merlano

The process of truth disclosure: an assessment of the results of information during the diagnostic phase in patients with cancer
Annals of Oncology Advance Access published on January 15, 2009
Ann Oncol 2009 20: 941-945; doi:10.1093/annonc/mdn709 [Abstract] [Full Text] [PDF] [Request Permissions]  

phase I and pharmacokinetics

Get checked abstract K. Fujita, W. Ichikawa, W. Yamamoto, H. Endo, F. Nagashima, R. Tanaka, T. Miya, K. Araki, K. Kodama, Y. Sunakawa, M. Narabayashi, K. Miwa, Y. Ando, Y. Akiyama, K. Kawara, and Y. Sasaki

Fixed dosing and pharmacokinetics of S-1 in Japanese cancer patients with large body surface areas
Annals of Oncology Advance Access published on January 15, 2009
Ann Oncol 2009 20: 946-949; doi:10.1093/annonc/mdn718 [Abstract] [Full Text] [PDF] [Request Permissions]  

epidemiology

Get checked abstract E. Hiripi, J. Lorenzo Bermejo, J. Sundquist, and K. Hemminki

Familial gastrointestinal carcinoid tumours and associated cancers
Annals of Oncology Advance Access published on January 15, 2009
Ann Oncol 2009 20: 950-954; doi:10.1093/annonc/mdn706 [Abstract] [Full Text] [PDF] [Request Permissions]  

sarcomas and melanoma

Get checked abstract M. S. Kim, S.-Y. Lee, T. R. Lee, W. H. Cho, W. S. Song, J.-S. Koh, J. A. Lee, J. Y. Yoo, and D.-G Jeon

Prognostic nomogram for predicting the 5-year probability of developing metastasis after neo-adjuvant chemotherapy and definitive surgery for AJCC stage II extremity osteosarcoma
Annals of Oncology Advance Access published on January 19, 2009
Ann Oncol 2009 20: 955-960; doi:10.1093/annonc/mdn723 [Abstract] [Full Text] [PDF] [Request Permissions]  

letters to the editor

E. Bandieri, A. Chiarolanza, M. Luppi, N. Magrini, A. M. Marata, and C. Ripamonti

Prescription of opioids in Italy: everything, but the morphine
Annals of Oncology Advance Access published on March 12, 2009
Ann Oncol 2009 20: 961-962; doi:10.1093/annonc/mdp041 [Extract] [Full Text] [PDF] [Request Permissions]  

F. Muggia

BRCA-deficient animal models and cisplatin resistance
Ann Oncol 2009 20: 962; doi:10.1093/annonc/mdp055 [Extract] [Full Text] [PDF] [Request Permissions]  

S. Chourin, D. Georgescu, C. Gray, C. Guillemet, A. Loeb, C. Veyret, and J.-P. Basuyau

Value of CA 15-3 determination in the initial management of breast cancer patients
Annals of Oncology Advance Access published on March 19, 2009
Ann Oncol 2009 20: 962-964; doi:10.1093/annonc/mdp061 [Extract] [Full Text] [PDF] [Request Permissions]  

C. Serrate, Y. Loriot, T. De La Motte Rouge, M. Gross-Goupil, C. Massard, B. Escudier, A. Bossi, and K. Fizazi

Diethylstilbestrol (DES) retains activity and is a reasonable option in patients previously treated with docetaxel for castration-resistant prostate cancer
Ann Oncol 2009 20: 965; doi:10.1093/annonc/mdp112 [Extract] [Full Text] [PDF] [Request Permissions]  

M. D. Galsky, K. Simon, G. Sonpavde, T. E. Hutson, M. Fleming, G. V. Kondagunta, and W. Berry

Ketoconazole retains activity in patients with docetaxel-refractory prostate cancer
Ann Oncol 2009 20: 965-966; doi:10.1093/annonc/mdp199 [Extract] [Full Text] [PDF] [Request Permissions]  

A. Ravaud and M. Sire

Arterial hypertension and clinical benefit of sunitinib, sorafenib and bevacizumab in first and second-line treatment of metastatic renal cell cancer
Ann Oncol 2009 20: 966-967; doi:10.1093/annonc/mdp201 [Extract] [Full Text] [PDF] [Request Permissions]  

P. Bono and H. Joensuu

Reply to Arterial hypertension and clinical benefit of sunitinib, sorafenib and bevacizumab in first and second-line treatment of metastatic renal cell cancer
Ann Oncol 2009 20: 967; doi:10.1093/annonc/mdp204 [Extract] [Full Text] [PDF] [Request Permissions]  

O. Mir, S. Ropert, J. Alexandre, and F. Goldwasser

Hypertension as a surrogate marker for the activity of anti-VEGF agents
Ann Oncol 2009 20: 967-970; doi:10.1093/annonc/mdp206 [Extract] [Full Text] [PDF] [Request Permissions]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.